Squeeze Report — July 3, 2026
A cluster of biotech and healthcare names (IBRX, SGMT, CRVS, NEO) dominates the top of the list, but the conviction is split: IBRX and SGMT offer genuine squeeze math with fundamental fragility, while NEO and ORKA show that a high squeeze score alone is a trap if short interest is already declining or negligible. The most actionable setups today pair extreme cost-to-borrow with a specific, near-term catalyst—not just a generic earnings date.
Today's top short-squeeze candidates
- #1ORICOric Pharmaceuticals, Inc. Com86
43% of float sold short · 10.3 days to cover · +48% over 20 days
SI 43%DTC 10.3$11.64+48% 20dHealthcare - #2AVTXAvalo Therapeutics, Inc. Commo82
68% of float sold short · 5.5 days to cover · +37% over 20 days
SI 68%DTC 5.5$18.84+37% 20dHealthcare - #3GPGIGPGI, Inc.81
The 18-day cover period is extreme, but a 44% rally has already occurred and massive dilution risk from Platinum Equity’s shelf registration caps the upside.
SI 36%DTC 18.1$16.75+44% 20dIndustrials - #4CRVSCorvus Pharmaceuticals, Inc. C81
A 14-day cover period and fresh $18M institutional buy suggest a slow-burn squeeze is possible, but the lack of borrow pain keeps urgency low.
SI 25%DTC 14.4$15.23+31% 20dHealthcare - #5CADLCandel Therapeutics, Inc. Comm81
29% of float sold short · 7.6 days to cover · +12% over 20 days
SI 29%DTC 7.6$9.83+12% 20dHealthcare - #6CERTCertara, Inc. Common Stock80
A guidance cut, CFO exit, and multiple law firm investigations overwhelm the squeeze structure, with the 24% rally likely driven by a now-completed Russell 2000 inclusion.
SI 27%DTC 7.3$6.97+24% 20dHealthcare - #7VERAVera Therapeutics, Inc. Class79
20% of float sold short · 10.4 days to cover · +32% over 20 days
SI 20%DTC 10.4$41.20+32% 20dHealthcare - #8SGMTSagimet Biosciences Inc. Serie78
Heavy short interest and unanimous insider buying set the stage, but the real spark would be a positive pipeline update at the July 15 Leerink conference.
SI 19%DTC 9.0$7.61+11% 20dHealthcare - #9DRVNDriven Brands Holdings Inc. Co78
16% of float sold short · 8.5 days to cover · +13% over 20 days
SI 16%DTC 8.5$14.47+13% 20dConsumer Cyclical - #10LIONLionsgate Studios Corp.77
Shorts are trapped near post-M&A highs with tight borrow, and a low-bar Q1 earnings report on Aug 6 could force a reckoning.
SI 44%DTC 5.7$14.66+10% 20dCommunication Services - #11CELCCelcuity Inc. Common Stock77
40% of float sold short · 4.3 days to cover · +21% over 20 days
SI 40%DTC 4.3$107.95+21% 20dHealthcare - #12IMVTImmunovant, Inc. Common Stock77
25% of float sold short · 14.1 days to cover · +25% over 20 days
SI 25%DTC 14.1$38.79+25% 20dHealthcare - #13REPLReplimune Group, Inc. Common S77
30% of float sold short · 4.8 days to cover · +16% over 20 days
SI 30%DTC 4.8$11.58+16% 20dHealthcare - #14PTCTPTC Therapeutics, Inc. Common77
16% of float sold short · 7.8 days to cover · +21% over 20 days
SI 16%DTC 7.8$83.31+21% 20dHealthcare - #15NTSTNetSTREIT Corp.76
36% of float sold short · 26.0 days to cover · +10% over 20 days
SI 36%DTC 26.0$21.66+10% 20dReal Estate
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →